1. Home
  2. ZURA vs DDL Comparison

ZURA vs DDL Comparison

Compare ZURA & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$0.97

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Logo Dingdong (Cayman) Limited (each two representing three)

DDL

Dingdong (Cayman) Limited (each two representing three)

N/A

Current Price

$1.68

Market Cap

494.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
DDL
Founded
2022
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
494.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ZURA
DDL
Price
$0.97
$1.68
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
★ 6.7M
295.2K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$9.66
P/E Ratio
★ N/A
$16.08
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$1.66
52 Week High
$7.25
$3.41

Technical Indicators

Market Signals
Indicator
ZURA
DDL
Relative Strength Index (RSI) 24.64 33.69
Support Level $0.93 N/A
Resistance Level $5.97 $1.96
Average True Range (ATR) 0.23 0.11
MACD -0.15 -0.00
Stochastic Oscillator 0.46 7.14

Price Performance

Historical Comparison
ZURA
DDL

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd are a foremost fresh grocery e-commerce company in mainland China with sustainable growth. It directly provide users and households with fresh groceries, prepared food and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. The Group operates and manages its business as a single segment. The Group generates substantially all of its revenues from customers in the PRC.

Share on Social Networks: